| scholarly article | Q13442814 |
| P50 | author | Toshiharu Shinoka | Q92342853 |
| P2093 | author name string | Toshihiro Shoji | |
| Yuichi Matsuzaki | |||
| Kelly John | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
| Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis | Q27013736 | ||
| Vessel bioengineering | Q27016183 | ||
| 3D bioprinting of tissues and organs | Q28245289 | ||
| Tissue engineering | Q29617288 | ||
| Functional arteries grown in vitro | Q33858809 | ||
| Antithrombogenic modification of small-diameter microfibrous vascular grafts | Q33998552 | ||
| An overview of tissue and whole organ decellularization processes. | Q34162830 | ||
| Additive manufacturing techniques for the production of tissue engineering constructs | Q34485006 | ||
| Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model | Q34674589 | ||
| Biomaterials in the development and future of vascular grafts | Q35058479 | ||
| Pediatric inpatient hospital resource use for congenital heart defects | Q35578662 | ||
| A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts | Q35609601 | ||
| What is the best material for extracardiac Fontan operation? | Q50955137 | ||
| Bioink properties before, during and after 3D bioprinting. | Q51156234 | ||
| Definitions of terms relating to the structure and processing of sols, gels, networks, and inorganic-organic hybrid materials (IUPAC Recommendations 2007) | Q56432744 | ||
| Recent trends in bioinks for 3D printing | Q60015738 | ||
| A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties | Q63990952 | ||
| Spatial and temporal changes in compliance following implantation of bioresorbable vascular grafts | Q67590200 | ||
| In vitro association of type III collagen with elastin and with its solubilized peptides | Q67919382 | ||
| A blood vessel model constructed from collagen and cultured vascular cells | Q69983909 | ||
| Transplantation of a tissue-engineered pulmonary artery | Q73548268 | ||
| Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study | Q83732473 | ||
| Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model | Q84974407 | ||
| The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery | Q87443782 | ||
| The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration | Q87711553 | ||
| Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts | Q89114857 | ||
| 3D bioprinting of tissues and organs for regenerative medicine | Q89499526 | ||
| Kinetics of endothelial cell seeding | Q93635573 | ||
| Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI | Q35609635 | ||
| Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts | Q35901287 | ||
| Smart materials as scaffolds for tissue engineering | Q36060657 | ||
| Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model | Q36088850 | ||
| Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs | Q36351460 | ||
| Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds | Q36757706 | ||
| Chitosan and its derivatives for tissue engineering applications | Q36947585 | ||
| Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. | Q37026285 | ||
| Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model | Q37304957 | ||
| Organ printing: tissue spheroids as building blocks | Q37379489 | ||
| Mucin covalently bonded to microfibers improves the patency of vascular grafts | Q37419171 | ||
| Nerve regeneration and elastin formation within poly(glycerol sebacate)-based synthetic arterial grafts one-year post-implantation in a rat model | Q37438427 | ||
| Current progress in 3D printing for cardiovascular tissue engineering | Q38379746 | ||
| An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia | Q38491646 | ||
| From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues | Q38774307 | ||
| Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model | Q38784714 | ||
| Three-dimensional bioprinting of complex cell laden alginate hydrogel structures | Q38810134 | ||
| Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation | Q39863541 | ||
| Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft | Q40964808 | ||
| Human tissue-engineered blood vessels for adult arterial revascularization | Q42382267 | ||
| A tough biodegradable elastomer | Q42814492 | ||
| Correction: Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae. | Q43112096 | ||
| Late-term results of tissue-engineered vascular grafts in humans | Q43182712 | ||
| In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding | Q43563146 | ||
| Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model | Q43708239 | ||
| Kinetics of collagen deposition within bioresorbable and nonresorbable vascular prostheses | Q44013483 | ||
| Successful application of tissue engineered vascular autografts: clinical experience | Q44181125 | ||
| Functional neointima characterization of vascular prostheses in human | Q44781819 | ||
| Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells | Q46533885 | ||
| Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source. | Q47136650 | ||
| Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts | Q47721071 | ||
| Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status | Q47868970 | ||
| Tissue-Engineered Vascular Grafts in Children with Congenital Heart Disease: Intermediate Term Followup. | Q50086198 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P577 | publication date | 2019-03-27 | |
| P1433 | published in | Applied Sciences | Q27725631 |
| P1476 | title | The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care | |
| P478 | volume | 9 |
Search more.